Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/23/2012 | CA2522379C The severe acute respiratory syndrome coronavirus |
10/23/2012 | CA2475949C Stabilisation of double-stranded nucleic acids using proteins |
10/23/2012 | CA2469599C Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
10/23/2012 | CA2444735C Lipoxygenase |
10/23/2012 | CA2439263C Three hybrid assay system |
10/23/2012 | CA2439260C Models and methods for determining systemic properties of regulated reaction networks |
10/23/2012 | CA2431972C Thermostable lipolytic enzyme variant |
10/23/2012 | CA2422162C Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof |
10/23/2012 | CA2420555C Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
10/23/2012 | CA2419322C Enhanced homologous recombination mediated by lambda recombination proteins |
10/23/2012 | CA2418802C Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same |
10/23/2012 | CA2412494C Agonist anti-trk-c monoclonal antibodies |
10/23/2012 | CA2386141C A novel polypeptide and gene encoding the same |
10/23/2012 | CA2384978C Udp-n-acetylglucosamine: galactose-.beta.1,3-n-acetylgalactosamine-.alpha.-r/(glcnac to galnac) .beta.1,6-n-acetylglucosaminyltransferase, c2gnt3 |
10/23/2012 | CA2374350C Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 97 and 98 |
10/23/2012 | CA2361009C Her-2/neu fusion proteins |
10/23/2012 | CA2359840C Glycosylated leptin compositions and related methods |
10/23/2012 | CA2331199C Isolated mannanases for use in treating cellulosic or synthetic fibers |
10/23/2012 | CA2315282C Single-chain polypeptides comprising troponin i and troponin c |
10/23/2012 | CA2262510C Expression system derived from the lipase regulation cascade of pseudomonas alcaligenes |
10/23/2012 | CA2257839C Gamma-heregulin |
10/18/2012 | WO2012142509A1 Decreased polysaccharide o-acetylation |
10/18/2012 | WO2012142458A1 Antisense modulation of ptp1b expression |
10/18/2012 | WO2012142401A2 Novel bacterial expression plasmid |
10/18/2012 | WO2012142371A1 Synthetic genes |
10/18/2012 | WO2012142313A2 Micro-rna inhibitors and their uses in disease |
10/18/2012 | WO2012142311A1 Self-reproducing hybrid plants |
10/18/2012 | WO2012142299A2 Improved cassava |
10/18/2012 | WO2012142213A2 Safe sequencing system |
10/18/2012 | WO2012142171A2 Improved cellulase variants |
10/18/2012 | WO2012142106A1 Identification and the use of krp mutants in plants |
10/18/2012 | WO2012141798A1 Adam6 mice |
10/18/2012 | WO2012141568A1 A method of regulating lignin content in the plant of hevea brasiliensis |
10/18/2012 | WO2012141554A2 Complex in which an anti-cotinine antibody is bound to a binder material of cotinine and a binding substance, and a use therefor |
10/18/2012 | WO2012141547A2 Enhanced-activity modified beta-glucosidase and a manufacturing method for bioethanol using same |
10/18/2012 | WO2012141504A2 Brg-1-derived bromodomain, and use thereof |
10/18/2012 | WO2012141445A2 Method for analyzing the risk of hepatoma onset for chronic patients of hepatitis type b, and method of predicting same |
10/18/2012 | WO2012141324A1 Method and kit for detecting 5-hydroxymethylcytosine in nucleic acids |
10/18/2012 | WO2012141280A1 Dna vaccine |
10/18/2012 | WO2012141201A1 Peptide for cancer immunotherapy and method using same |
10/18/2012 | WO2012141026A1 Fusion protein |
10/18/2012 | WO2012140677A2 ISOLATION, CLONING, SEQUENCING AND FUNCTIONAL ANALYSIS OF β-CASEIN PROMOTER ALONG WITH THE REGIONS OF EXON1, INTRON1 AND EXON2 USING MAMMARY GLAND DERIVED CELL LINE OF BUFFALO (BUBULUS BUBALIS) |
10/18/2012 | WO2012140376A1 Therapeutic peptides and use thereof against huntington's disease |
10/18/2012 | WO2012140234A1 Modulation of mirna in diseases with aberrant angiogenesis |
10/18/2012 | WO2012140230A1 Novel methods of modifying plant phenotype |
10/18/2012 | WO2012140068A1 New vaccines for prevention and treatment of tuberculosis |
10/18/2012 | WO2012139964A1 Expression method |
10/18/2012 | WO2012139628A1 Coding polypurine hairpins for the treatment of cancer |
10/18/2012 | WO2012139532A1 Use of oxhs4 gene in controlling rice drought resistance |
10/18/2012 | WO2012139416A1 Method of ultrasonic-aided agrobacterium mediated gene transformation in plant germinated seed |
10/18/2012 | WO2012139254A1 Method of selectively driving gene expression in anaerobic tissue by alcohol dehydrogenase promoter and uses thereof |
10/18/2012 | WO2012139225A1 Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a |
10/18/2012 | WO2012139195A1 EXPRESSION SYSTEM WITH SAR ELEMENT FROM IFNα2 |
10/18/2012 | WO2012115459A9 1-cystein peroxiredoxin promoter derived from oryza sativa l. |
10/18/2012 | WO2012115390A9 Method for preparing lactulose from lactose using cellobiose 2-epimerase or n-acetyl glucosamin 2-epimerase |
10/18/2012 | WO2012104059A3 Lentiviral vector comprising at least two tar elements |
10/18/2012 | WO2012100176A3 Macrocyclic compounds with a hybrid peptidic/non-peptidic backbone and methods for their preparation |
10/18/2012 | WO2012099448A3 RECOMBINANT ADENOVIRUS EXPRESSING αA-CRYSTALLIN GENE AND GENE THERAPY FOR RETINAL VASCULAR DISEASE USING SAME |
10/18/2012 | WO2012098119A3 Protein expression in plants |
10/18/2012 | WO2012095843A8 Organisms with altered steroidal saponin and steroidal alkaloid levels and methods for producing same |
10/18/2012 | WO2012095244A3 Enzymatic synthesis of active pharmaceutical ingredient and intermediates thereof |
10/18/2012 | WO2012094511A3 Compositions and methods for the treatment of orthopedic disease or injury |
10/18/2012 | WO2012092374A3 Express humanization of antibodies |
10/18/2012 | WO2012088577A3 Recombinant mycobacterium sp. protein, immunodiagnostic test and tuberculosis vaccine |
10/18/2012 | WO2012028526A3 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use |
10/18/2012 | US20120266335 Synthetic genes |
10/18/2012 | US20120266333 Wheat plants having increased resistance to imidazolinone herbicides |
10/18/2012 | US20120266331 Wheat Plants Having Increased Resistance To Imidazolinone Herbicides |
10/18/2012 | US20120266330 Wheat Plants Having Increased Resistance To Imidazolinone Herbicides |
10/18/2012 | US20120266329 Nucleic Acids and Proteins and Methods for Making and Using Them |
10/18/2012 | US20120266328 Celluloytic enzymes, nucleic acids encoding them and methods for making and using them |
10/18/2012 | US20120266327 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
10/18/2012 | US20120266326 Freeze tolerant eucalyptus |
10/18/2012 | US20120266325 Plant Stress Tolerance Related Protein GmSIK1 and Encoding Gene and Use Thereof |
10/18/2012 | US20120266324 Self-Reproducing Hybrid Plants |
10/18/2012 | US20120266269 Gene controlling chasmogamy/cleistogamy of plant and use thereof |
10/18/2012 | US20120266268 Genetic manipulation of the at-hook domain in plant ahl genes to modulate cell growth |
10/18/2012 | US20120266267 Rice and products thereof having starch with an increased proportion of amylose |
10/18/2012 | US20120266266 Methods of producing genetically-modified eukaryotic cells with rationally-designed meganucleases |
10/18/2012 | US20120266265 Transgenic avians and protein production |
10/18/2012 | US20120266262 Methods and compositions relating to zpa polypeptides |
10/18/2012 | US20120266261 Neurovirulent strain of the west nile virus and uses thereof |
10/18/2012 | US20120264960 NOVEL ACETYL-CoA CARBOXYLASE |
10/18/2012 | US20120264921 Human antibodies specifically binding to the hepatitis b virus surface antigen |
10/18/2012 | US20120264919 Interleukin-21 receptor binding proteins |
10/18/2012 | US20120264914 Spider silk proteins and methods for producing spider silk proteins |
10/18/2012 | US20120264814 Isolation, Cloning, Sequencing and Functional analysis of ss-casein promoter along with the regions of exon1, intron1 and exon2 using mammary gland derived cell line of Buffalo (Bubulus bubalis) |
10/18/2012 | US20120264811 Elongator Proteins and Use Thereof as DNA Demethylases |
10/18/2012 | US20120264809 RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions |
10/18/2012 | US20120264807 Method for introducing sirna into cells by photochemical internalisation |
10/18/2012 | US20120264805 Medicament for the treatment and prevention of liver failure |
10/18/2012 | US20120264686 Modified erythropoietin (epo) polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof |
10/18/2012 | US20120264675 Cmv gene products promote cancer stem cell growth |
10/18/2012 | US20120264625 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
10/18/2012 | US20120264616 Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides |
10/18/2012 | US20120264218 Induction of pluripotent cells |
10/18/2012 | US20120264217 Respiratory syncytial virus expression vectors |
10/18/2012 | US20120264191 Protein and dna sequence encoding a cold adapted-subtilisin-like activity |
10/18/2012 | US20120264179 Microorganisms for the production of adipic acid and other compounds |
10/18/2012 | US20120264176 Alpha-Amylases |